文献库，生知库 | 链接生命科学的每一步

Response to "A commentary on 'Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery'"

对“利用多种细胞死亡模式预测三阴性乳腺癌患者术后预后和药物敏感性”一文的评论的回应

Xie, Jindong; Deng, Xinpei; Yang, Anli; Zheng, Shaoquan; Tang, Yuhui; Xie, Yi; Zhang, Junsheng; Tang, Hailin; Chen, Wenkuan; Zou, Yutian; Xie, Xiaoming

细胞生物学

Co-targeting ferroptosis and immune evasion through small molecules in breast cancer

利用小分子药物协同靶向乳腺癌中的铁死亡和免疫逃逸

期刊:Journal of Translational Internal Medicine

影响因子:7.4

doi:10.1515/jtim-2025-0093

Zhou, Jianbo; Yang, Wangji; Tang, Hailin; Zou, Yutian; Zhou, Zhaokai; Peng, Cheng; Peng, Fu

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy

HER2阳性乳腺癌伴有浸润性微乳头状癌成分，表现出免疫抑制性微环境和对新辅助治疗的耐药性。

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1623675

Zhang, Lulu; Zhou, Lijia; Yang, Anli; Zheng, Shaoquan; Chen, Keming; Zou, Yutian; Zhou, Qingru; Wang, Daining; Xu, Fei; Huang, Jiajia; Yuan, Zhongyu; Wang, Shusen; Shi, Yanxia; Sun, Peng; An, Xin

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

癌症相关成纤维细胞来源的细胞外囊泡：肿瘤微环境中的调节因子和治疗靶点

期刊:Cancer Drug Resistance

影响因子:5.2

doi:10.20517/cdr.2024.152

Xie, Jindong; Lin, Xinmei; Deng, Xinpei; Tang, Hailin; Zou, Yutian; Chen, Wenkuan; Xie, Xiaoming

The Dual Roles of Circular RNAs in Breast Cancer Distant Metastasis and Their Clinical Applications

环状RNA在乳腺癌远处转移中的双重作用及其临床应用

期刊:Journal of Cancer

影响因子:3.2

doi:10.7150/jca.111680

Bao, Qing; Zhang, Huan; Chen, Pangzhou; Wu, Song; Zou, Yutian; Wang, Huan; Cao, Jingna; Zhou, Wen; Guan, Ziyun; Tang, Hailin

Single-Cell RNA Transcriptomics and Multi-omics Analyses Reveal the Clinical Effects of Acupuncture on Methadone Reduction

单细胞RNA转录组学和多组学分析揭示针灸对美沙酮减量的临床疗效

期刊:

影响因子:

doi:10.34133/research.0741

Chen, Yiming; Fan, Baochao; Zeng, Jingchun; Zou, Yutian; Tao, Chenyang; Chen, Chen; Zhang, Peiming; Liang, Jian; Qi, Fangfang; Tang, Hailin; Lu, Liming

Histone lactylation as a driver of metabolic reprogramming and immune evasion

组蛋白乳酸化作为代谢重编程和免疫逃逸的驱动因素

期刊:

影响因子:

doi:10.1515/mr-2024-0091

Cai, Qiaoting; Deng, Wei; Zou, Yutian; Chen, Zhe-Sheng; Tang, Hailin

IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.

肿瘤相关巨噬细胞中的 IRG1/衣康酸/NRF2/GSH 轴驱动 BRCA1 缺陷型乳腺癌的治疗耐药性和免疫逃逸。

期刊:

影响因子:

doi:10.1101/2025.10.14.682312

Nan Yabing, O'keefe Sophie, He Xiadi, Luo Qingyu, Wu Xiaowei, Ni Jing, Zou Yutian, Meade Jerryd Marcus, Li Yutong, Ji Renlei, Mohammad Anwaruddin, Kumar Pankaj, Wang Qiwei, Zhao Jean J

Targeting the neuro-immune crosstalk in breast cancer brain metastases

靶向乳腺癌脑转移中的神经免疫串扰

Clinical approaches to overcome PARP inhibitor resistance

克服PARP抑制剂耐药性的临床方法

Response to "A commentary on 'Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery'"

对“利用多种细胞死亡模式预测三阴性乳腺癌患者术后预后和药物敏感性”一文的评论的回应

Co-targeting ferroptosis and immune evasion through small molecules in breast cancer

利用小分子药物协同靶向乳腺癌中的铁死亡和免疫逃逸

HER2-positive breast cancer with invasive micropapillary carcinoma component shows immunosuppressive microenvironment and resistance to neoadjuvant therapy

HER2阳性乳腺癌伴有浸润性微乳头状癌成分，表现出免疫抑制性微环境和对新辅助治疗的耐药性。

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

癌症相关成纤维细胞来源的细胞外囊泡：肿瘤微环境中的调节因子和治疗靶点

The Dual Roles of Circular RNAs in Breast Cancer Distant Metastasis and Their Clinical Applications

环状RNA在乳腺癌远处转移中的双重作用及其临床应用

Single-Cell RNA Transcriptomics and Multi-omics Analyses Reveal the Clinical Effects of Acupuncture on Methadone Reduction

单细胞RNA转录组学和多组学分析揭示针灸对美沙酮减量的临床疗效

Histone lactylation as a driver of metabolic reprogramming and immune evasion

组蛋白乳酸化作为代谢重编程和免疫逃逸的驱动因素

IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.

肿瘤相关巨噬细胞中的 IRG1/衣康酸/NRF2/GSH 轴驱动 BRCA1 缺陷型乳腺癌的治疗耐药性和免疫逃逸。